4//SEC Filing
Shukla Sanjay 4
Accession 0001209191-22-007485
CIK 0001339970other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:52 PM ET
Size
8.1 KB
Accession
0001209191-22-007485
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Award
Restricted Stock Units
2022-02-03+41,500→ 41,500 total→ Common Stock (41,500 underlying) - Award
Employee Stock Option (right to buy)
2022-02-03+83,000→ 83,000 totalExercise: $5.52Exp: 2032-02-03→ Common Stock (83,000 underlying)
Footnotes (3)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 3, 2022, such that this option will be fully exercisable on February 3, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001671026
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:52 PM ET
- Size
- 8.1 KB